Understanding Leukemia: Types, Symptoms, and Modern Management
Updated: Nov 11
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer: What is leukemia?
Leukemia is a blood cancer in which the bone marrow produces abnormal white blood cells that crowd out healthy ones. [1] It causes symptoms like persistent fatigue, easy bruising and frequent infections. [1] Some types are curable, while others are managed through long-term remission with chemotherapy, targeted drugs or stem cell transplants. About 70% of adults survive at least five years.
What the research says
Targeted therapy transformed chronic myeloid leukemia. With almost 11 years of follow-up, people with chronic-phase CML who started imatinib had an estimated 10-year overall survival of 83.3%, and 82.8% achieved a complete cytogenetic response (Hochhaus et al., New England Journal of Medicine, 2017) [3].
Childhood leukemia survival keeps improving. Among 21,626 children and young people with acute lymphoblastic leukemia in US trials, 5-year survival rose from 83.7% in 1990–1994 to 90.4% in 2000–2005 (Hunger et al., Journal of Clinical Oncology, 2012) [4].
How is leukemia classified, and what are its subtypes?
Healthcare providers classify leukemia based on two primary factors: how quickly the disease progresses and the specific type of white blood cell that is affected. [1] Acute leukemias involve the rapid multiplication of immature "blast" cells and require immediate intervention, whereas chronic leukemias develop more slowly over many years.
Main Subtype | Primary Characteristics | Common Demographics |
Acute Myelogenous (AML) | Rapidly progressing; affects myeloid cells. | Most common acute type in adults. [1] |
Acute Lymphoblastic (ALL) | Rapidly progressing; affects lymphoid cells. | Common in children; also affects adults. [1] |
Chronic Lymphocytic (CLL) | Slowly progressing; may be asymptomatic for years. | Typically affects adults aged 65 and older. |
Chronic Myelogenous (CML) | Slowly progressing; often managed as a chronic illness. | More common in adults aged 55 and older. |
Beyond these four primary categories, there are less common forms such as hairy cell leukemia and chronic myelomonocytic leukemia (CMML). Each subtype requires a unique clinical approach to achieve the best possible outcome for the patient.

What are the common symptoms of leukemia?
Because leukemia affects the production of all blood cell types, its symptoms can be diverse and systemic. Many of the early signs mimic other common illnesses, which is why persistent symptoms lasting more than two weeks should always be evaluated by a healthcare professional.
Bleeding and Bruising: Frequent nosebleeds, bleeding gums, and unexplained bruises are common due to low platelet counts. Tiny red spots on the skin, known as petechiae, may also appear. [1]
Systemic Fatigue: A profound sense of exhaustion that does not improve with rest is a hallmark of the anemia caused by leukemia.
Recurrent Infections: Because healthy white blood cells are crowded out, the immune system is weakened, leading to frequent bacterial infections like pneumonia.
Physical Discomfort: Patients may experience bone or joint pain, night sweats, unexplained weight loss, and swollen lymph nodes in the neck, underarm, or groin.
Organ Involvement: An enlarged liver or spleen can cause a feeling of fullness or bloating in the abdomen.
What causes leukemia, and what are its risk factors and complications?
The underlying cause of leukemia is a mutation in the DNA of blood cells that instructs them to multiply without dying. [1] While the exact trigger for these mutations remains unknown, several risk factors have been identified. [1] These include prior exposure to high doses of radiation, certain chemicals like benzene, smoking, and previous cancer treatments such as chemotherapy or radiation therapy.

As the disease progresses, it can lead to significant complications. Anemia (low red blood cells) causes weakness, while thrombocytopenia (low platelets) increases the risk of dangerous bleeding. Furthermore, leukemia cells can spread to other parts of the body, including the brain, liver, and testes, potentially leading to organ damage.
How is leukemia diagnosed and treated today?
Diagnosing leukemia involves a thorough physical exam followed by specific clinical tests. A complete blood count (CBC) is used to check for abnormal levels of white blood cells, while flow cytometry and peripheral blood smears help identify the presence of leukemia cells. For a definitive diagnosis, providers often perform bone marrow aspirations and biopsies to compare the ratio of healthy to abnormal cells.
Treatment Modality | Description and Application |
Chemotherapy | The most common treatment; uses powerful drugs to kill cancer cells. |
Targeted Therapy | Medications that specifically target the proteins or DNA changes in leukemia cells. [2] |
Immunotherapy | Advanced treatments like CAR T-cell therapy that boost the immune system's response. [2] |
Stem Cell Transplant | Replaces damaged bone marrow with healthy stem cells from a donor. [2] |
Modern medicine has transformed the outlook for many patients. For instance, chronic myelogenous leukemia (CML) is now often managed as a long-term chronic condition with daily medication. Supportive care, including palliative care and survivorship programs, also plays a crucial role in managing side effects and mental health.
What is the outlook and long-term survival for leukemia?
The prognosis for leukemia has improved significantly over recent decades. In the United States, approximately 70% of adults diagnosed with leukemia are alive five years after their diagnosis. While the condition can recur even after a successful remission, ongoing monitoring and advancements in therapy continue to enhance the quality and length of life for those affected.

Conclusion
Leukemia is a challenging diagnosis, but it is no longer the insurmountable obstacle it once was. With a wide range of effective treatments and a growing focus on survivorship, many adults are able to live full lives after their diagnosis. Staying vigilant about symptoms and working closely with a specialized medical team are the most important steps an individual can take toward achieving and maintaining remission.
If you or a loved one are experiencing persistent fatigue, unusual bruising, or frequent infections that last more than two weeks, consult a healthcare provider immediately. Early diagnostic testing is essential for identifying the type of leukemia and beginning the appropriate treatment plan as soon as possible.
Frequently Asked Questions
1. What is leukemia?
Leukemia is a group of blood cancers that start in the bone marrow when abnormal white blood cells crowd out healthy ones.
2. Is leukemia curable?
Some types are curable, especially in children, while many adult types are managed through long-term remission where symptoms are absent.
3. What are the main types?
The four main types are Acute Myelogenous (AML), Acute Lymphoblastic (ALL), Chronic Lymphocytic (CLL), and Chronic Myelogenous (CML).
4. Who is most at risk?
In adults, it most commonly affects those aged 65 and older, though it can occur at any age.
5. What are the first signs?
Early signs often include persistent fatigue, fever, night sweats, and easy bruising or bleeding.
6. Does leukemia cause bone pain?
Yes, the accumulation of abnormal cells in the bone marrow can lead to bone and joint pain or tenderness.
7. How is it diagnosed?
Doctors use blood tests (like CBC), bone marrow biopsies, and imaging tests (like CT or MRI) to confirm the diagnosis.
8. What is remission?
Remission means that symptoms have disappeared and tests can no longer detect leukemia cells in the body.
9. Can smoking cause leukemia?
Smoking and exposure to second-hand smoke are recognized risk factors that can increase the chance of developing the disease.
10. What is a stem cell transplant?
A stem cell transplant is a procedure that replaces a patient's damaged bone marrow with healthy stem cells from a compatible donor.
11. How does chemotherapy work for leukemia?
Chemotherapy uses drugs to kill rapidly dividing cancer cells throughout the body and is a primary treatment for most types.
12. What is the survival rate for adults?
Approximately 7 out of 10 adults in the U.S. survive at least five years after their initial diagnosis.
13. Can leukemia spread to other organs?
Yes, leukemia cells can travel through the blood to the liver, spleen, lymph nodes, brain, and other organs.
14. What are "late effects"?
Late effects are medical issues that may develop months or even years after cancer treatment has been completed.
15. Is leukemia hereditary?
While DNA mutations cause the disease, it is generally not considered a hereditary condition passed directly from parents to children.
Related Reading
Immunophenotyping: How It Identifies Blood Cells to Diagnose Leukemia and Lymphoma explains the marker test used to diagnose and classify leukemia and lymphoma.
Learn more in our guide to Complete Blood Count (CBC): What It Measures, Normal Ranges and Abnormal Results.
Learn more in our guide to Bone Marrow Biopsy: Why It's Done, What to Expect, Pain and Recovery.
Flow Cytometry: What It Is, Why It's Done, How It Works and Results explains the lab test that sorts and counts cells by their surface markers to help diagnose and monitor blood cancers and immune conditions.
Learn more in our guide to Blood Tests for Cancer: Types, What They Can Show and What Results Mean.
References
Mayo Clinic Staff. Leukemia - Symptoms and causes. Mayo Clinic. December 20, 2024. https://www.mayoclinic.org/diseases-conditions/leukemia/symptoms-causes/syc-20374373
Mayo Clinic Staff. Leukemia - Diagnosis and treatment. Mayo Clinic. December 20, 2024. https://www.mayoclinic.org/diseases-conditions/leukemia/diagnosis-treatment/drc-20374378
Hochhaus A, et al. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia. N Engl J Med. 2017;376(10):917-927. PMID 28273028. https://doi.org/10.1056/NEJMoa1609324
Hunger SP, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol. 2012;30(14):1663-9. PMID 22412151. https://doi.org/10.1200/JCO.2011.37.8018
Medical Disclaimer
The information provided in this article is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here.




Comments